503 related articles for article (PubMed ID: 29896301)
21. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
[TBL] [Abstract][Full Text] [Related]
22. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
[TBL] [Abstract][Full Text] [Related]
23. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
24. Dual Stimuli-Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy.
Jiao X; Wang Z; Wang F; Wen Y
Chemphyschem; 2019 Dec; 20(24):3271-3275. PubMed ID: 31654459
[TBL] [Abstract][Full Text] [Related]
25. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
[TBL] [Abstract][Full Text] [Related]
26. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
Agiba AM; Arreola-RamÃrez JL; Carbajal V; Segura-Medina P
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
[TBL] [Abstract][Full Text] [Related]
27. Recent advances in magnetic nanocarriers for tumor treatment.
Zhu J; Wang J; Li Y
Biomed Pharmacother; 2023 Mar; 159():114227. PubMed ID: 36638597
[TBL] [Abstract][Full Text] [Related]
28. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
29. Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release.
Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang CY; Zhang S
Int J Nanomedicine; 2019; 14():8001-8011. PubMed ID: 31632014
[TBL] [Abstract][Full Text] [Related]
30. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
[TBL] [Abstract][Full Text] [Related]
31. Calcium phosphate-based organic-inorganic hybrid nanocarriers with pH-responsive on/off switch for photodynamic therapy.
Nomoto T; Fukushima S; Kumagai M; Miyazaki K; Inoue A; Mi P; Maeda Y; Toh K; Matsumoto Y; Morimoto Y; Kishimura A; Nishiyama N; Kataoka K
Biomater Sci; 2016 May; 4(5):826-38. PubMed ID: 26971562
[TBL] [Abstract][Full Text] [Related]
32. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
33. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
[TBL] [Abstract][Full Text] [Related]
34. pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy.
Xu C; Song RJ; Lu P; Chen JC; Zhou YQ; Shen G; Jiang MJ; Zhang W
Int J Nanomedicine; 2018; 13():7229-7249. PubMed ID: 30510415
[TBL] [Abstract][Full Text] [Related]
35. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy.
Ghalehkhondabi V; Soleymani M; Fazlali A
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130168. PubMed ID: 38365162
[TBL] [Abstract][Full Text] [Related]
37. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
38. Facile preparation of pH-responsive polyurethane nanocarrier for oral delivery.
Nabid MR; Omrani I
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():532-7. PubMed ID: 27612744
[TBL] [Abstract][Full Text] [Related]
39. Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review.
Shaik BB; Katari NK; Jonnalagadda SB
Ther Deliv; 2023 Sep; 14(9):595-613. PubMed ID: 37877308
[TBL] [Abstract][Full Text] [Related]
40. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]